Pharmaceutical Research and Manufacturers of America

Drug Makers Find New Ways to Thwart Generic Competition
Drug Makers Find New Ways to Thwart Generic CompetitionBrand-name drug companies are finding creative ways to extend patent protection, causing patient access problems.
Judge rules: Orphan drugs not subject to 340B discountsJudge Rudolph Contreras ruled against the Department of Health and Human Services by saying that pharma companies do not have to offer rural and cancer hospitals that serve low-income populations 340B discounts on orphan drugs.
NIH partners with industry to find best biological targets of diseaseThe National Institutes of Health, FDA, 10 biopharmaceutical companies, the Pharmaceutical Research and Manufacturers of America, and several nonprofit organizations have launched an unprecedented public/private partnership to transform the current model for identifying and validating the most promising biological targets of disease for new diagnostics and drug development.
Pharma, government, and nonprofit organizations unite in search for new therapiesThe National Institutes of Health (NIH), FDA, 10 biopharmaceutical companies, the Pharmaceutical Research and Manufacturers of America, and several nonprofit organizations have launched an unprecedented public/private partnership to “transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets of disease,” announced a recent statement from the NIH.